This site provides information on the EPIC study and details on case recruitment for veterinary professionals worldwide. Pimobendan is a prescription only medicine, licensed for the treatment of congestive heart failure due to mitral valve disease or dilated cardiomyopathy.

The EPIC Trial site is intended for veterinary professionals. By clicking 'Continue' you are affirming that you are a veterinary professional.

Evaluating Pimobendan in Cardiomegaly
Media & Journalists  •  Contact  •  Helpful Links  •  FAQs  •  Site Map

Video: An Investigator's Point of View

Each of the 36 EPIC Trial Investigators are board-certified veterinary cardiologists, enhancing the treatment and education of canine heart disease by participating in the EPIC study. Please take a moment to view share his/her thoughts on the importance – and necessity – of this groundbreaking study.
  Professor Jens Häggström
Swedish University of Agricultural Sciences
Faculty of Veterinary Medicine and Animal Science
Uppsala, Sweden

  Professor Adrian Boswood
Royal Veterinary College
Veterinary Clinical Sciences
Hatfield, Hertfordshire, UK


Investigator Sign in

Investigators, please sign in here.

Prof. Jens Häggström

An Investigator's Point of View

Prof. Adrian Boswood

An Investigator's Point of View